{"id":64544,"date":"2020-12-31T23:00:35","date_gmt":"2020-12-31T15:00:35","guid":{"rendered":"https:\/\/www.chinapulse.com\/?p=154223"},"modified":"2020-12-31T23:00:35","modified_gmt":"2020-12-31T15:00:35","slug":"covid-19-china-approves-sinopharm-vaccine-for-common-use","status":"publish","type":"post","link":"https:\/\/www.chinalegalblog.com\/en\/2020\/12\/31\/covid-19-china-approves-sinopharm-vaccine-for-common-use\/","title":{"rendered":"Covid-19: China approves Sinopharm vaccine for common use"},"content":{"rendered":"<p>Covid-19: China approves Sinopharm vaccine for common use 1 hour ago<\/p>\n<p>\u201cAfter a series of strict reviews, verification, test and data analysis in accordance with the law and procedures, it is concluded that the known and potential benefits of Sinopharm\u2019s new inactivated coronavirus vaccine are bigger than the known and potential risks, and it fully meets the pre-set requirements of conditional marketing standards,\u201d he mentioned.&#8230;<\/p>\n<p>This news comes via <a href=\"https:\/\/www.chinapulse.com\/\"  title=\"Best source for Chinese news in English\">ChinaPulse.com, which delivers news, data, analysis, and insights on Chinese business, travel, finance, health, military, investment, and technology<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Covid-19: China approves Sinopharm vaccine for common use 1 hour ago<br \/>\n\u201cAfter a series of strict reviews, verification, test and data analysis in accordance with the law and procedures, it is concluded that the known and potential benefits of Sinopharm\u2019s&#8230;<\/p>\n","protected":false},"author":250,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[144,213,194],"tags":[10323,10324,7035],"class_list":["post-64544","post","type-post","status-publish","format-standard","hentry","category-china","category-china-news","category-news-chinese-law","tag-coronavirus","tag-covid-19","tag-vaccine"],"_links":{"self":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts\/64544","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/users\/250"}],"replies":[{"embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/comments?post=64544"}],"version-history":[{"count":1,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts\/64544\/revisions"}],"predecessor-version":[{"id":64545,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts\/64544\/revisions\/64545"}],"wp:attachment":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/media?parent=64544"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/categories?post=64544"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/tags?post=64544"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}